Search

Your search keyword '"Donkervoort, Sandra"' showing total 658 results

Search Constraints

Start Over You searched for: Author "Donkervoort, Sandra" Remove constraint Author: "Donkervoort, Sandra"
658 results on '"Donkervoort, Sandra"'

Search Results

1. Exome copy number variant detection, analysis, and classification in a large cohort of families with undiagnosed rare genetic disease.

2. Cost-effectiveness of general practitioner- versus surgeon-led colon cancer survivorship care: an economic evaluation alongside a randomised controlled trial

3. Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy.

4. SNUPN deficiency causes a recessive muscular dystrophy due to RNA mis-splicing and ECM dysregulation

5. Digenic inheritance involving a muscle-specific protein kinase and the giant titin protein causes a skeletal muscle myopathy

7. Unraveling factors associated with textbook outcome after cholecystectomy in patients with uncomplicated cholecystolithiasis: A posthoc analysis of individual data of 1,124 patients

8. CIAO1 loss of function causes a neuromuscular disorder with compromise of nucleocytoplasmic Fe-S enzymes

10. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

11. Variants in DTNA cause a mild, dominantly inherited muscular dystrophy

12. International retrospective natural history study of LMNA-related congenital muscular dystrophy

13. International retrospective natural history study of LMNA-related congenital muscular dystrophy.

14. Persistent and new-onset symptoms after cholecystectomy in patients with uncomplicated symptomatic cholecystolithiasis: A post hoc analysis of 2 prospective clinical trials

15. Adult MTM1-related myopathy carriers: Classification based on deep phenotyping.

16. Restrictive Strategy vs Usual Care for Cholecystectomy in Patients With Abdominal Pain and Gallstones: 5-Year Follow-Up of the SECURE Randomized Clinical Trial.

17. A cross-sectional analysis of clinical evaluation in 35 individuals with mutations of the valosin-containing protein gene.

18. Heterozygous frameshift variants in HNRNPA2B1 cause early-onset oculopharyngeal muscular dystrophy

19. The expanding clinical and genetic spectrum of DYNC1H1-related disorders

20. Genome Sequencing for Diagnosing Rare Diseases

21. Phase 1 Open-Label Study of Omigapil in Patients With LAMA2- or COL6-Related Dystrophy

22. Effects of HMGCR deficiency on skeletal muscle development

23. Unraveling factors associated with textbook outcome after cholecystectomy in patients with uncomplicated cholecystolithiasis: A posthoc analysis of individual data of 1,124 patients

26. Childhood Onset Amyotrophic Lateral Sclerosis Associated with SPTLC2 Gain-of-Function Pathogenic Variants: Clinical, Genetic, and Biochemical Insights (P4-8.001)

27. Pathogenic TNNI1 variants disrupt sarcomere contractility resulting in hypo- and hypercontractile muscle disease

28. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis

29. The recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy

30. Differential inclusion of NEB exons 143 and 144 provides insight into NEB-related myopathy variant interpretation and disease manifestation

31. Detecting missed diagnoses of spinal muscular atrophy in genome, exome, and panel sequencing datasets

32. Clinical, immunohistochemical and genetic characterization of splice-altering biallelic DES variants: therapeutic implications

33. Psychological Impact of Predictive Genetic Testing in VCP Inclusion Body Myopathy, Paget Disease of Bone and Frontotemporal Dementia.

34. BET1 variants establish impaired vesicular transport as a cause for muscular dystrophy with epilepsy

35. Loss of function mutations in GEMIN5 cause a neurodevelopmental disorder

36. Innocuous pressure sensation requires A-type afferents but not functional ΡΙΕΖΟ2 channels in humans

38. Cross-sectional Neuromuscular Phenotyping Study of Patients With Arhinia With SMCHD1 Variants

39. Clinical, Pathologic, and Mutational Spectrum of Dystroglycanopathy Caused by LARGE Mutations

40. A splice donor mutation in NAA10 results in the dysregulation of the retinoic acid signalling pathway and causes Lenz microphthalmia syndrome.

41. Frequency of Prader-Willi syndrome in births conceived via assisted reproductive technology.

42. Loss of Function of the Cytoplasmic Fe-S Assembly Protein CIAO1 Causes a Neuromuscular Disorder with Compromise of Nucleocytoplasmic Fe-S Enzymes

43. Recurrentde-novo gain-of-functionmutation inSPTLC2confirms dysregulated sphingolipid production to cause juvenile amyotrophic lateral sclerosis

44. Recurrent de novoSPTLC2variant causes childhood-onset amyotrophic lateral sclerosis (ALS) by excess sphingolipid synthesis

45. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

46. Biallelic variants inHMGCS1are a novel cause of rare rigid spine syndrome

47. Exome copy number variant detection, analysis and classification in a large cohort of families with undiagnosed rare genetic disease

48. Persistent and new-onset symptoms after cholecystectomy in patients with uncomplicated symptomatic cholecystolithiasis: A post hoc analysis of 2 prospective clinical trials

49. Association of Initial Maximal Motor Ability with Long-term Functional Outcome in Patients with COL6-related Dystrophies

50. The clinical, histological, and genotypic spectrum of SEPN1-related myopathy: A case series

Catalog

Books, media, physical & digital resources